| Note |
Another reason to switch. With the November 1 Authority Listing change to thioridazine, and the addition of a caution that thioridazine may cause serious cardiac arrhythmias, the reasons for re-assessment and switching to Zyprexa are even more compelling. Not only does Zyprexa effectively treat positive, negative and depressive symptoms, it does so with no clinically significant QTc prolongation. Switching is simple and with a once-daily starting and therapeutic dose range of 5-20 mg, Zyprexa encourages compliance and long-term success. Zyprexa (Olanzapine). Make the change. |
